For everyone lots of information, keep scrolling down! 

New Benefits Center Site

Requires sign in. If you don't already know your pin# use your hire date to start.

 

United Retiree Service Center 

1-888-825-0188  (M-F 7am - 5pm Central Time)

For aeromedical information you might want to check this website from Dr. Samuelson. He has a lot of related links to the FAA, permitted medicines and related pilot health concern subjects.

Aeromedical

http://tinyurl.com/3bfsa5

FAA Accepted Medications | Updated 6/1/07

Scroll down, it's a long list.

For all interested parties:

For involuntary medical insurance terminations, call Kathy Perricone at 847 700 6635, at WHQ. She has been very helpful to me. The United Retired Pilots 1114 Committee is gathering data on this problem. If you would send the details of your cases to Mr. Jack Carriglio, P.O. Box 617880, Chicago, IL 60661, it will help in this endeavor. See our request in the RUPA website under "Medical" and thanks.

Alan L. Black

Good afternoon,

Blue Cross / Blue Shield

1-800-535-9825

MEDCO CUSTOMER SERVICE : 800-864-1425
And if you are NOT satisfied with the results:
Contact: JILL CHAPMAN at UAL Headquarters in Chicago
847-700-6578

SHE will jump on MEDCO and have them calling you to resolve denial of payment for drug repayment ! She has helped me twice in the last month resolve disputes with NO FURTHER submissions or paperwork ! ! .SHE IS A QUEEN ! ! !

BOB SOERGEL...SFOFO{retired}

 

Nov 10 2007

Earlier today one of our members asked me: "...has anyone compared our medical benefits with alternative med programs?"

I shared the question with Mort Wax, President of RUAEA along with several other former RUAEA officers who are also members of our group. Here's Mort's comprehensive response.

(Note: As you'll see below at the time of the analysis in 2005 Mort was Exec VP of RUAEA)


Steve, as it happens, we did do a comparison of medical plans to United's plans. Or, more accurately, we had it done for us by an outside agency. In the March, 2005 RUAEA Newsletter, I wrote the following:

FROM THE EXECUTIVE VICE-PRESIDENT

Members of RUAEA and of RUPA have continued to question whether (1) there is a better alternative to United’s existing health insurance group plan, and (2) what alternatives would be available in the event there is no United medical/prescription coverage plan. Recently, we agreed to jointly determine answers to these two questions. There are two organizations which have been providing assistance to furloughed United employees with needs involving health plans. Arrangements were made to meet with them. On January 20, President Marlin Lade, RUAEA member Chick McErlean and I together with President Rich Bouska and Dick Schultz of RUPA met with representatives of IMA of Colorado and of AXA Advisors (some of them furloughed pilots) to receive information on available options. Their conclusions follow.

First, as to a better alternative to United's existing health insurance group plan. For a different group plan, United would have to contribute as it does to the current retiree plan. There is no option to a group plan if United does not contribute because, by law, an employer/employee relationship must exist in order for a group plan to be possible. Neither RUAEA nor RUPA could be a sponsor because neither organization provides an employer/employee relationship. For the analysis, Aetna, Blue Cross, CIGNA, UHC and Great West were polled and IMA's recommendation is to stay with current United programâ€. Of course, while United's group plan exists, the prerogative exists for anyone to enter into an individual contract with a health insurance provider. Please note that most individual plans either do not have, or have reduced, prescription cost coverage compared to United’s coverage. Some other things to be considered are covered below.

Second, as to what alternatives would be available in the event there is no United medical/prescription coverage plan. For pre-65 retirees, the only options are individual programs that are individually underwritten, that vary based upon need and that vary in premium levels. Because these programs are individually underwritten, specific medical conditions and related complications can be excluded or be entirely declined for coverage. In the latter case, the only available option would be a State uninsured pool. For post-65 retirees who are covered by Medicare A & B, there are 10 supplemental (Medigap) standard plus Medicare Advantage plans available. Again, please note that in the event of United medical plan termination pre-existing conditions covered under the cancelled group plan will be covered only within 63 days of group plan termination when applying to a replacement supplemental plan.

If you are interested in reviewing options and costs available to you, we recommend that you access either or both the Defined Contribution Benefit Solutions and Medicare websites at www.chooseyourbenefits.com or www.medicare.gov. There you can compare your options and their costs, their advantages and drawbacks.

Our only advice to you is the following:


1. Be careful! There may be no guaranteed coverage upon selection of an individual contract carrier. Applicants may have to go through the carrier's regular health screening process.


2. Be careful! Once you leave United's group plan you will not be able to re- enroll unless you can provide proof that you had continuous coverage in an eligible plan while your United plan coverage was dropped (see Section 2 of your Summary Plan Description).

Mort Wax
Executive Vice-President

Steve, to the best of my knowledge, the information above continues to be generally valid. There have been some adjustments to the various plans both from United and from outside agencies but I don't think the analysis is much different than what we recommended in '05. Feel free to share the above with... our associates....

Best Regards Mort

Today, 12/17/09, Alan Black sent me the following:

Dear Doug,

Good to hear from you. I recently attended the luncheon of the "North Sounders" and was also asked to clarify what seems to be a spreading misconception concerning retiree medical coverage. Briefly, the agreement states that the insurance premium for our medical coverage will remain fixed until January 2010. At that time, the premium may be increased by no more than 4.5% per year. There is nothing in the present agreement terminating our medical insurance at any date certain contrary to rumors on the Internet. In our original negotiations we felt a 4.5% premium increase cap was reasonable and we also felt that sacrificing our $10K life insurance was an acceptable trade-off for this cap. All of the retiree groups negotiating this benefit have now been harmonized into a single standard insurance program. Even though ALPA does not represent retired pilots, the IAM vigorously protects the benefits of retired mechanics. Our benefits are effectively being protected by other unionized employees at United. This agreement could be modified in the future should a subsequent bankruptcy be declared by the airline using an 1114 committee negotiations to establish new terms of insurance. However, things seem to be looking up for United and therefore our medical coverage should continue until the last retiree expires.

Please note that my email has changed to the one I am using now -- blackbirds9909@ gmail.com

Best Wishes,

Alan Black


International SOS Provides Employees With Valuable Assistance While Traveling Overseas

Have you ever wondered what you would do in an emergency situation while traveling outside of your home country? What if your passport was stolen or you lost your prescription medicine? In today's volatile world, finding yourself in the middle of political or social protests is not even far-fetched.

"The safety and well-being of all of United's people is our No. 1 priority," says Michael Quiello, Vice President-Corporate Safety, Security, Quality and Environment. "So we engaged one of the top firms in the industry, International SOS, to provide security and medical assistance in emergency and non-emergency situations."

The new program is available to all employees, retirees and travel eligibles (including Enrolled Friends). Prior to your travels, visit the International SOS Web site (www.internationalsos.com ) which offers medical alerts, cultural tips, visa information, country facts and other relevant information. It's easy to access from the member's section by entering United's member ID number: 11BYCA000027.

If you need to find a doctor or have a general health question, medical and dental referrals are simply a phone call away. The centers are available 24 hours a day, 7 days a week.

For crews on an active ID and other employees traveling on company business, International SOS will provide medical resources in an emergency or evacuation to a medical center of excellence.

For additional information, check the International SOS link on the Travel page of SkyNet under Travel Information. You can also print a member card or view a list of Frequently Asked Questions. Be sure to print your membership card and keep it handy as you travel. It contains our corporate membership number and phone numbers to access International SOS.

See SkyNet for more details.


Prostate Cancer Drug Breakthrough For Aggressive Form Of Disease
22 Jul 2008

http://www.medicaln ewstoday. com/

A new trial drug called abiraterone has shown a high success rate at treating men with an aggressive, drug resistant, and often fatal form of prostate cancer. 70 to 80 per cent of the men on the trial experienced dramatic reductions in PSA (a protein marker for prostate cancer) and tumour shrinkage, even in tumours that had spread to bone and other tissue.

The study, which is published in the 21st July online issue of the Journal of Clinical Oncology, was the work of researchers based at the Institute of Cancer Research (where the drug was discovered) and The Royal Marsden Hospital in London, and funded by Cougar Biotechnology, Inc of Los Angeles, California.

The results of the Phase 1 clinical trial suggest that abiraterone could treat up to 10,000 British men diagnosed each year with the aggressive and often fatal form of prostate cancer.

Lead investigator on the trial, Dr Johann de Bono, of the Institute of Cancer Research in Sutton, Surrey, UK, said the drug worked by blocking hormones that drive the growth of prostate cancer tumours.

"Clinical benefits included evidence of PSA falls and tumour shrinkage which was observed in 70-80 per cent of patients," said de Bono, explaining that they used CAT, MRI and bone scans, as well as blood levels of PSA to measure tumour shrinkage.

"Abiraterone works not only in blocking the generation of these hormones in the testes, but also elsewhere in the body, including generation of hormones in the cancer itself," he added.

All the patients on the trial had an aggressive form of prostate cancer whose tumours were thought to be producing their own supply of hormones, which may explain why treatment with drugs that only block hormones produced by the testes did not work.

The researchers decided to carry out the study because up to that point, studies on what is called castration-resistan t prostate cancer (CRPC) showed that the tumours were still being driven by supplies of the male hormone androgen. They decided to trial abiraterone because it is a precision drug that targets a specific enzyme that plays a key role in the synthesis of androgen, called cytochrome P (CYP) 17.

For the trial, they enrolled 21 men who had prostate cancer that was resistant to multiple hormonal therapies; none of them had received chemotherapy. The men were split into three groups, and given an escalating daily dose of the drug (starting at 250 and finishing with 2,000 mg).

The results showed that:

* Abiraterone acetate was well tolerated.
* Anticipated side effects such as high blood pressure, low potassium and swelling in the lower limbs were successfully managed with other drugs (mineralocorticoid receptor antagonist to balance the effect of secondary mineralocorticoid excess).
* Anti tumour effects were observed in all doses, but because the effect appeared to level off at 1,000 mg, this was selected as the dose for expanding the trial to include another 9 patients.
* PSA (prostate specific antigen) levels went down by 30 per cent in 14 patients (66 per cent of the participants) , by 50 per cent in 12 patients (57 per cent of participants) and 90 per cent in 6 patients (29 per cent of participants) and lasted between 69 to 578 days or more.

De Bono and colleagues concluded that:

"CYP17 blockade by abiraterone acetate is safe and has significant antitumor activity in CRPC." They also said that these findings confirm that this type of prostate cancer (CRPC) depends on signalling by the androgen hormone.

"The Royal Marsden patients in this study have been monitored for up to two-and-a-half years and with continued use of abiraterone they were able to control their disease with few side-effects. A number of patients were able to stop taking morphine for the relief of bone pain," said de Bono.

"We hope that abiraterone will eventually offer them real hope of an effective way of managing their condition and prolonging their lives," he said, estimating that the drug should be available for general use from 2011. Until then it will only be available to patients on clinical trials.

Prostate cancer is the most common cancer among men in the UK, where 35,000 new cases are diagnosed and 10,000 men die of the disease every year, nearly all from the CRPC form.

One patient on the trial, Robin Wood, 65, who lives in Wokingham, near Reading, was diagnosed with an aggressive drug resistant form of prostate cancer in May 2007. He said in a statement from the Institute of Cancer Research that:

"My prostate was very cancerous and I had only a one in five chance of being alive by the end of 2008."

"However, abiraterone radically changed that, with my health improving within a week of beginning the drug trial," said Wood.

"I have just returned from the huge Round The Island Yacht Race, which is a testament to my better health. I was diagnosed with prostate cancer after reading about the symptoms in the newspaper and immediately went to the GP. My life might have turned out very differently if I hadn't read that article," he added.

Another patient, Simon Bush, 50, a bank manager from London, was also enrolled on the trial.

"Last year I was in severe pain because of my prostate cancer, which had worsened and spread to my bones," said Bush.

"Chemotherapy and other treatments had failed and news that I had very few treatment options available to me was devastating for my family," he added, saying that abiraterone has allowed him to continue with his interests like fitness and travelling, and to "have a year so far of near normality".

Abiraterone is owned by BTG and licensed to Cougar Biotechnology, Inc of Los Angeles, California. Further trials of the drug are under way, including an international study on men with prostate cancer and a UK study on women with breast cancer.

Chief Executive of the Institute of Cancer Research Professor Peter Rigby, said the trial result showed what can be achieved by funding world leading cancer research:

"Today we can reveal a potential major advance in the treatment of prostate cancer. We hope with the generous contribution of the community we can continue to develop better treatments to combat many cancers."

These sentiments were echoed by Cally Palmer, Chief Executive of The Royal Marsden NHS Foundation Trust, who said:

"The results of this study show just how important abiraterone is set to become in the treatment of men with prostate cancer and highlights the national importance of funding pioneering cancer research."

"Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistan t Prostate Cancer Commonly Remains Hormone Driven.
Gerhardt Attard, Alison H.M. Reid, Timothy A. Yap, Florence Raynaud, Mitch Dowsett, Sarah Settatree, Mary Barrett, Christopher Parker, Vanessa Martins, Elizabeth Folkerd, Jeremy Clark, Colin S. Cooper, Stan B. Kaye, David Dearnaley, Gloria Lee, and Johann S. de Bono
Journal of Clinical Oncology, Published online July 21, 2008.
DOI: 10.1200/JCO. 2007.15.9749

Click here for Abstract.


Dr. Russell L. Blaylock, M.D., Tip of the Week

Feb 3, 2008

Statin Drugs: Bad News Gets Worse

I've been telling you for years what made health headlines this past
week: the cholesterol- lowering effect from statins has not been show
to be related to a reduction in heart attacks and strokes (my special report "Cholesterol Drugs Are Dangerous" was first published in 2004).

Now we learn that one such drug, Vytorin, simply does not even work
for its intended purpose; the reduction of artery plaque. You read
that correctly – "does not work."

The mainstream media can no longer ignore the mounting evidence that these drugs are not a panacea. One study found that for every
hundred people taking statins for three years, only one death will
be prevented. Other studies hint that the number is far higher –
that up to 250 people would have to take statins for at least three
years to prevent a single death!

Statins do not seem to benefit postmenopausal women, or anyone
without a history of cardiovascular disease. Yet, doctors are
prescribing statins for anyone with an elevated cholesterol and for
all diabetics no matter their cholesterol level.

The fact that 50 percent of all strokes and heart attacks have
absolutely nothing to do with elevated cholesterol levels is a
guarded secret. And in addition, these drugs are associated with
major complications and side effects like depletion of the body's
essential energy molecule coenzyme Q10 (CoQ10), which can lead to
congestive heart failure, extreme muscle weakness, neurological
disorders and even death.

And all statin drugs have been associated with causing or promoting
cancer in experimental animals. This is especially important since
millions of Americans have been advised to take these drugs for the
rest of their lives.

The results of one study were especially frightening: Statin drugs
produced significant suppression of vital immune cells called helper
T-cells. These cells play a major role in protecting us against
cancer and fungal, bacterial and viral infections.

The immune suppression was so powerful that authors of the paper
even suggested that statins might be used to prevent organ rejection
in transplant patients. The drugs tested in this study included
Lipitor, Mevacor and Pravachol.

Chronic immune suppression in these millions would mean that a
tremendous number would be at high risk of developing cancer, and
those already having cancer would see tremendous growth and spread
of their cancers.

A Danish study found that those taking statin drugs long term were 4
to 14 times more likely to develop nerve degeneration leading to
difficulty walking and painful extremities.

So, do you still want to take statins? Or would you rather use safe,
natural methods to protect your heart? If so, stop believing the
cholesterol myth and read my special report "Heart Saver: Protect
Yourself from Heart Attacks and Strokes" to find what you need to
know.
____________ _________ _________ _____

Or, as George says, read http://www.ravnskov .nu/myth2. htm and
the "About the Author" at the bottom of that article.

George also says to kill the pleomorphic bacterial L-forms that
cause the symptoms of chronic illness of unknown cause to begin with.

Wishing you wellness!!!

George Howell

P.S. If you take less of Big Pharms drugs, you will reduce your
monthly drug bill. Most of those drugs are not meant to get
you "cured" of the cause that bring about the various symptoms.
They are just meant to TREAT symptoms!! And make PROFITS for Big Pharm. Even one of their executives mentioned that to a
Congressional Hearing some time back. David Williams, a Los Angelos Times reporter did an expose' of the NIH' lowering the Recommended Maximum for Total Cholesterol from a test figure of 260 to 200. Williams found that six of the nine doctors making that
recommendation was somehow on the "fiancial take" of those companies that make the supposedly cholesterol- lowering drugs. That article made it into the Wall Street Journal, too. Nothing came of that
expose'. I wonder why!?!?!? :)


Original Message ----- From George Howell
Sent: Friday, October 05, 2007 3:22 PM


Canadian Health System and the Direction of the US

One seldom hears of complaints of having to wait very long lenghts
of time for medical treatment (even if the treatment is not the
best) in the U.S., except for maybe organ transplants.

Socialized whatever just dumbs down the system, and creates
providers that do not have to care, because they know that they will
still earn a livelihood. Look at our public schools if you need to
see an example. Or, the biggest failure of all in socialism
supplying every need of its population, the U.S.S.R.

READ  ON:

The difference in unhappiness in the U.S. and Canadian health
systems is that for those that are paying for health coverage, it is
the length of time that one has to wait for getting medical service.
In the U.S., you will get to be treated fairly soon with the current
thinking/medical practice, but in the Canadian system, you will wait
an inappropriate length of time...even if you are willing to pay...
to get the same inept medical treatment as in the U.S.!

Yes, there are complaints about the quality of medical care in both
systems. However, that is more depended upon the orthodox medical
community of both systems insistance on holding to the Koch
Postulates and not really exploring new medical thinking.

As Don Hodges pointed out in his article about the Mac versus IBM
compatibles, "It's easier to do what everyone else is doing, and
it's easier to stick with what you already have."

Med docs are taught the Koch Postulates in med school, and
regimented into adhering to them afterwards, by out-of-date medical
review boards holding licenses at risk.

Medical doctors will just go along with the current thinking rather
than risk their means of livelihood.

Wishing all wellness!!!

George Howell

Jan, 2008  Many older but still pertinent postings about medical issues are still here but may be 'way down the page.

FAA Accepted Medications | Updated 6/1/07

(It's a long list!)

FAA Medications Master List

The FAA has not published an official list of approved drugs. The following list of FAA accepted medications is the most accurate and complete information available on the listed date. This "master list" was developed by Pilot Medical Solutions through communication with the FAA.

Medications included in this list are approved only for the condition listed on a case by case basis. Some medications listed may not be approved for a given individual and medications not listed may also be acceptable.

New medications usually require a 1 year review hold beginning on the date of FDA approval. This is to establish a side effect profile beyond the manufacturers published material and does not include herbal preparations or supplements.

To assure FAA medical eligibility
call 800-699-4457
for a free consultation.
Federal Aviation Regulations (Part 61) require a person who holds a current medical certificate shall not act as pilot in command, or in any other capacity as a required pilot flight crewmember, while that person:
"Knows or has reason to know of any medical condition that would make the person unable to meet the requirements for the medical certificate necessary for the pilot operation; or
Is taking medication or receiving other treatment for a medical condition that results in the person being unable to meet the requirements for the medical certificate necessary for the pilot operation."

Type Cntrl +F or Cmd +F to find any word on this page. Hold Cntrl+F keys or Cmd+F to find any drug or condition listed on this page.
Acne - Most antibiotics are acceptable to the FAA. Pilots should wait 48 hours after the initial dose to assure no adverse side effects occur. Accutane (Isotretinoin) is also approved with the restriction "NOT VALID FOR NIGHT FLYING" on the medical.

ADD - See Attention Deficit Disorder

Arrhythmia (heart) - Some commonly prescribed drugs such as Tikosyn (Dofetilide) are not approved by the FAA. The following anti-arrhythmic medications are approved on a case by case basis and subject to a compete cardiovascular evaluation.

* Arava (Leflunomide)
* Betapace (Sotalol)
* Calan (Verapamil)
* Cordarone, Pacerone (Amiodarone-up to 200 mg per day for A-Fib only)
* Lanoxin (Digoxin)
* Norpace (Disopyramide)
* Rythmol (Propafenone)
* Tambocor (Flecainide Acetate)

MORE

Allergy, Cold, Decongestants - Sudafed (Pseudoephedrine) and Entex (Phenylpropanolamin e) are approved by the FAA provided they are not combined with an antihistamine.

Claritin (Loratadine) , Clarinex (Desloratadine) and Allegra (Fexofenadine) are acceptable to the FAA provided no negative side effects are experienced. Vitamin B-12 or other prophylactic injections are approved provided there are no side effects.

Approved Inhalers include:

* Afrin (Pseudoephedrine)
* Atrovent (Ipratropium) CASE BY CASE ONLY
* Beconase (Beclomethasone Dipropionate)
* Flonase (Fluticasone Propionate)
* Nasalcrom (Cromolyn Sodium)
* Nasalide (Flunisolide)
* Vancenase (Beclomethasone Dipropionate)

Sedating medications are not acceptable. This includes but is not limited to: Cetirazine (Zyrtec), Dipenhydramine (Benadryl) and Astelin (Azelastine) Nasal Inhaler. MORE

Antacids / G.I. Medications - The following medications are approved by the FAA on a case by case basis only. Pilots With Ulcers

* Aciphex (Rabeprazole)
* Asacol (Mesalamine)
* Axid (Nizatidine)
* Azulfidine ((Sulfasalazine) )
* Cytotec (Misoprostol)
* Dipentum (Olsalazine)
* Mylanta
* Pepcid (Famotidine)
* Prevacid (Lansoprazole)
* Prilosec (Omeprazole)
* Propulsid
* Protonix (Pantoprazole sodium)
* Reglan (Metoclopramide hydrochloride)
* Rolaids
* Tagamet (Cimetidine)
* Tums
* Zantac (Ranitidine)

Anti-Bacterial - Flagyl (Metronidazole)

Antibiotics - The use of antibiotics is usually permissible, providing the drug has been taken for long enough (usually 48 hours) to rule out the possibility of adverse effects.

A partial list of acceptable antibiotics include:

* Azactam (Aztreonam)
* Augmentin, Amoxil (Amoxicillin)
* Biaxin (Clarithromycin)
* Cipro (Ciprofloxacin)
* Floxin (Ofloxicin)
* Keflex (Cephalexin)
* Levaquin (Levofloxacin)
* Monodox (Doxycycline)
* Zithromax (Azithromycin)

Anti-Coagulants - The following may be approved on a case by case basis:

* Aspirin
* (Salicylate) Coumadin
* (Warfarin) Lovenox (Enoxaparin)
* Plavix (Clopidrogrel)
* Pletal (Cilostazol)
* Trental
(Pentoxifylline)

Anti-Depressants / Anxiety - With the exception of herbal preparations, SSRI medications are rarely approved by the FAA. MORE

Anti-Fungal - The following may be approved by the FAA on a case by case basis:

* Gris-PEG (Griseofulvin)
* Lamisil (Terbinafine)
* Sporanox (Traconazole)

Anti-Inflammatory & Arthritis - The following medications are usually FAA approved provided there are no side effects and the condition being treated does not preclude safe performance of flight duties:

* Acetaminophen
* Advil (Ibuprofen)
* Aleve (Naproxen Sodium)
* Ansaid
* Arava (Leflunomide)
* Arthrotec (Diclofenac)
* Asacol (Mesalamine)
* Aspirin
* Azulfidine (Sulfasalazine)
* Celebrex (Celecoxib)
* Cataflam (Diclofenac Sodium)
* Daypro (Oxaprozin)
* Dolobid (Diflunisal)
* Elmiron (Pentosan)
* Enbrel (Etanercept)
* Feldene (Piroxicam)
* Ibuprofen
* Imuran (Azothioprine)
* Indocin (Indomethacin)
* Lodine (Etodalac)
* Meclofenamate (Meclofenamic Acid)
* Mediprin
* Methotrexate (not approved for cancer)
* Mobic (Meloxicam)
* Motrin (Ibuprofen)
* MotrinIB (Ibuprofen)
* Naprosyn (Naproxen Sodium)
* Naproxen (Naproxen Sodium)
* Orudis (Ketoprofen)
* Oruvail (Ketoprofen)
* Plaquenil - May affect vision. FAA approval requires an eye evaluation
* Relafen (Nabumetone)
* Remicade (Infliximab)
* Rheumatrex (Methotrexate, not approved for cancer)
* Synvisc (Hylan G-F 20) Injections may be approved on a case by case basis
* Tylenol (Acetaminophen)
* Toradol (Ketorolac Tromethamine)
* Trexall (Methotrexate not approved for cancer)
* Voltaren (Diclofenac Sodium)

Anti-Malarial - The following medications are acceptable for malaria prophylaxis:

* Chloroquine Phosphate
* Malarone (Atovaquone + Proguanil HCL)

Anti-Viral - The following medications are approved by the FAA on a case by case basis:

* Famvir (Famciclovir)
* Fludara (Fludarabine)
* Hepsera (Adefovir Dipivoxil)
* Rebetol, Virazole (Ribavirin)
* Truvada (Emtricitabine / Tenofovir)
* Valtrex (Valacyclovir)
* Viread (Tenofovir Disoproxil Fumarate)
* Zerit (Stavudine)
* Zovirax (Acyclovir)

Anxiety - With the exception of herbal preparations (Saint Johns Wort), anti-anxiety medications, such as Paxil, are rarely approved by the FAA. MORE

Asthma / COPD - These conditions often require a combination of drugs which are usually approved by the FAA on an individual basis only. Prednisone is acceptable up to 20 mg only. Case by case approved medications include but may not be limited to:

* Advair, Flovent (Fluticasone Propiona)
* Accolate (Zafirlukast)
* Aerobid (Flunisolide)
* Azmacort (Tiamcinolone)
* Foradil (Formoterol)
* Proventil, Pentolin, Ventolin (Albuterol)
* Serevent (Salmeterol)
* Singulair (Montelukast)
* Theo-Dur, Uniphyl (Theophylline)
* Xolair (Omalizumab)
* Zyflo (Zileuton) MORE

Attention Deficit (ADD) - Ritalin (Methylphenidate Hydrochloride) , Adderall (Dextroamphetamine Sulfate) and Strattera (Atomoxetine Hydrochloride) are usually not approved by the FAA. Under rare circumstances, individuals using Ritalin have been approved with restrictions. Approval is more likely for adults due to the difficulty in accurately evaluating ADD in young people and typically requires time off medication prior to flight.

Benign Prostatic Hypertrophy (BPH) The following are approved by the FAA for the prevention or treatment of Benign Prostatic Hypertrophy (BPH) on a case by case basis:

* Avodart (Dutasteride)
* Cardura (Doxazosin Mesylate)
* Dibenzyline (Phenoxybenzamine HCL)
* Flomax (Tamsulosin HCL)
* Hytrin (Terazosin HCL)
* Minipress, Minizide (Prazosin HCL)
* Proscar (Finasteride)
* Saw Palmetto
* Uroxatral (Alfuzosin Hydrochloride)

Bi-Polar Disorder - With the exception of herbal preparations (Saint Johns Wort), psychotropic medications, such as lithium, are rarely approved by the FAA. MORE

Bladder Control - Ditropan (Oxybutynin Chloride) is no longer approved by the FAA. The following medications may be approved by the FAA for bladder control after 30 days of symptom-free use:

* Enablex (Darifenacin)
* Detrol (Tolterodine Tartrate)

Blood Thinners - The following are usually approved on a case by case basis:

* Aspirin
* (Salicylate) Coumadin
* (Warfarin) Lovenox (Enoxaparin)
* Plavix (Clopidrogrel)
* Pletal (Cilostazol)
* Trental
(Pentoxifylline)

With the exception of aspirin, detailed information regarding the underlying condition and INR's are required.

Blood Pressure (Hypertension) Centrally acting agents such as Guanethidine, Guanadrel, Guanabenz, Methyldopa, and Reserpine are not acceptable to the FAA.

The following medications are FAA approved on a case by case basis:

Alpha Blockers / Inhibitors

* Cardura (Doxazosin)
* Catapres (Clonidine)
* Dibenzyline (Phenoxybenzamine)
* Hytrin (Terazosin)
* Micardis (Telmisartan)
* Minipress, Minizide (Prazosin)

Beta Blockers

* Blocadren, Timolide (Timolol)
* Cartrol (Carteolol)
* Cibenzyline (Phenoxybenzamine)
* Coreg (Carvedilol)
* Corgard, Corzide (Nadolol)
* Inderal, Inderide, Innopran (Propranolol)
* Kerlone (Betaxolol)
* Levatol (Penbutolol)
* Lopressor, Toprol (Metoprolol)
* Normodyne, Trandate (Labetalol)
* Sectral (Acebutolol)
* Tenormin, Tenoretic (Atenolol)
* Visken (Pindolol)
* Zebeta, Ziac (Bisoprolol)

Calcium Channel Blockers

* Adalat, Procardia (Nifedipine)
* Caduet (Amlodipine Besylate + Atorvastatin Calcium)
* Cardizem, Dilacor, Tiazac (Diltiazem)
* Cardene (Nicardipine)
* Calan, Covera, Isoptin, Veralan, Tarka (Verapamil)
* DynaCirc (Isradipine)
* Norvasc, Lotrel (Amlodipine)
* Plendil, Lexxel (Felodipine)
* Posicor (Mibefradil)
* Sular (Nisoldipine)

Angiotensin Converting Enzyme (ACE) Inhibitors

* Aceon (Perindopril Erbumine)
* Accupril (Quinapril)
* Altace (Ramipril)
* Capoten, Capozide (Captopril)
* Lotensin (Benazepril)
* Mavik (Trandolapril)
* Monopril (Fosinopril)
* Prinivil, Prinzide, Zestril, Zestoretic (Lisinopril)
* Univasc, Unitrec (Moexipril)
* Vasotec, Vaseretic (Enalapril)

Angiotensin II Receptor Antagonists

* Atacand (Candesartan)
* Avapro, Avalide (Irbesartan)
* Benicar (Olmesartan Medoxomil)
* Benicar HCT (Olmesartan Medoxomil + Hydrochlorothiazide )
* Cozaar, Hyzaar (Losartan)
* Diovan (Valsartan)
* Micardis (Telmisartan)

Diuretics

* Aldactone, Aldactazide (Spironolactone)
* Bumex (Bumetanide)
* Camadex, Demadex (Torsemide)
* Diuril, Hydrochlorothiazide , HCTZ, Hydrodiuril, Oretic, Enduron (Thiazides)
* Dyazide, Maxzide, Moduretic (Combinations)
* Dyrenium (Triamterene)
* Lasix (Furosemide)
* Lozol (Indapamide)
* Mykrox (Metolazone)
* Zaroxolyn, Mykrox (Metolazone)

Botox - Botulinum Neurotoxin may be FAA approved on a case by case basis only for severe muscle cramps, cosmetic wrinkle treatments or diagnostic purposes.

Cancer - Most cancer treatment/medicatio ns, such as; Chemotherapy, must be completed prior to resuming flight duties. The drugs below may be accepted by the FAA on a case by case basis only:

* Femara (Letrozole)
* Nolvadex (Tamoxifen)
* Luprin, Eligard (Leuprolide Acetate) and Casodex / Zolodex (Bicalutamide) may be acceptable for pilots with prostate cancer.
* Radioactive seed implantation may be FAA approved after radioactivity is sufficiently reduced and side effects are absent. MORE

Cardiovascular - With the exception of chest-pain drugs (ISMO, IMDUR, ISORDIL), most cardiovascular medications are FAA approved. (see arrhythmia, blood pressure, blood thinners, cholesterol)

Cervical Dystonia - Botulinum Neurotoxin may be FAA approved on a case by case basis with extensive requirements and restrictions.

Cholesterol / Lipid Management - Most medications used in the treatment of hyperlipidemia or the management of cholesterol are approved by the FAA.
This includes but may not be limited to:

* Caduet (Amlodipine Besylate + Atorvastatin Calcium)
* Crestor (Rosuvastatin Calcium)
* Lipitor (Atorvastatin)
* Lopid (Gemfibrozil)
* Mevacor (Lovastatin)
* Niacin (Nicotinic Acid)
* Pravachol (Pravastatin)
* Precose (Acarbose)
* Questran,Cholestyra mine, Locholest, Prevalite (Cholestyramine Resin)
* Tricor (Fenofibrate)
* Vytorin (Ezetimibe / Simvastatin)
* WelChol (Colesevelam Hydrochloride)
* Zetia (Ezetimibe)
* Zocor (Simvastatin)

Contraceptives - Almost always approved

Cold - See Allergy / Cold Medications

Crohn's Disease - Pentasa (Mesalamine) , Imuran (Azothioprine) and Remicade (infliximab) are FAA approved on a case by case basis only.

Depression - With the exception of herbal preparations (Saint Johns Wort), anti-depressants, such as prozac and zoloft, are rarely approved by the FAA. MORE

Dermatological - Accutane is approved treatment of acne during daytime flight only. Most topical medications for acne or similar conditions may be approved by the FAA. Submit your medication

Diabetes - Humulin, Lantus (Insulin) is approved on a case by case basis for Class 3 medical certification only. With proper documentation, most oral hypoglycemic medications are approved for all classes. This includes:

* Actos (Pioglitazone)
* Amaryl (Glimeperide)
* Avandamet (Rosiglitazone Maleate + Metformin Hydrochloride)
* Avandia (Rosiglitazone)
* Byetta (Exenatide) A 30 day wait period is required if the airman is on any sulfonylurea class hypoglycemic drugs. A 14 day wait period is required if other diabetes medications are used by the pilot. A 2 hour wait period is required after each injection before flying.
* Diabeta or Glynase (Glyburide)
* Glucophage (Metformin)
* Glucotrol (Glipizide)
* Prandin (Repaglinide)
* Precose (Acarbose)
* Starlix (Nateglinide)

Some of these medications are not FAA approved in combination with other medications. Contact Us for a free consultation

Diarrhea - While this condition is usually self-limiting, the following medications may be used for minor occurrences:

* Imodium
* Kaopectate
* Lomotil (Diphenoxylate Hydrochloride)
* Pepto-Bismol

Other medications require discontinuation at least 48 hours prior to flight.

Diet - See Weight Loss/Management

Dry Mouth - See Xerostomia

DVT - Lovenox Sub-Q (Enoxaparin Sodium) may be FAA approved on a case by case basis only.

Endometriosis - Luprin / Lupron (Leuprolide) may be FAA approved on a case by case basis.

Erectile Dysfunction - Cialis (Tadalafil) is acceptable if used 36 or more hrs before flight.
Levitra (Vardenafil hydrochloride) and Viagra (Sildenafil Citrate) are approved by the FAA (acceptable to fly 6 hrs after use). MORE

Essential Thrombocytosis - Anagrilide is FAA approved on a case by case basis.

Gall Stones - Actigall (Ursidiol) is FAA approved on a case by case basis.

Gastrointestinal (G.I.) Issues (GERD, Irritable Bowel Syndrome, Etc.] - Librax and similar preparations containing psychotropic drugs are not acceptable to the FAA.

UNACCEPTABLE medications included but is not limited to:

* Diphenoxylate (Lomotil)
* Anticholinergics (Bentyl)
* Levsin (L-hyoscyamine)
* Librax (chlordiazepoxide and clidinium)
* Opiates (Paregoric)

The following medications are ACCEPTABLE on a case by case basis only:

* Aciphex (Rabeprazole)
* Asacol (Mesalamine)
* Axid (Nizatidine)
* Azulfidine (Sulfasalazine)
* Cytotec (Misoprostol)
* Dipentum (Olsalazine)
* Imodium (Loperamide) (LIMITED USE)
* Mylanta
* Nexium (Esomeprazole)
* Pepcid (Famotidine)
* Prevacid (Lansoprazole)
* Prilosec (Omeprazole)
* Propulsid (Cisapride)
* Protonix (Pantoprazole Sodium)
* Reglan (Metoclopramide Hydrochloride)
* Rolaids
* Tagamet (Cimetidine)
* Tums
* Zantac (Ranitidine)
* Zelnorm (Tegaserod maleate)

Gingivitis - Most mouthwash type medications, including prescriptions drugs such as Chlorhexidine Gluconate, are FAA approved.

Glaucoma - Most glaucoma medications such as Xalatan (Latanoprost) are FAA approved after proper evaluation. MORE

Gout - With detailed evaluation the following medications are usually FAA approved:

* Benemid (Probenecid)
* Colbenemid (Colchicine)
* Zyloprimare (Allopurinol)

Graves' Disease - Provided applicant is euthyroid, the following medications may be FAA approved on a case by case basis only:

* Tapazole (Methimazole)
* Propylthiouracil

Hair Growth - The following are FAA approved on a case by case basis:

* Propecia (Finisteride)
* Procaine (Procaine hydrochloride)
* Rogaine (Minoxidil)

Headaches - The following drugs are FAA approved on a case by case basis:

* Acetaminophen
* Advil (Ibuprofen)
* Aleve (Naproxen Sodium)
* Ansaid
* Aspirin
* Beta-Blockers (when labeled & approved by the FDA for headache type)
* Caffergot
* Calcium-Channel Blockers
* Ibuprofen
* Imitrex
* Innopran XL (Propranolol Hydrochloride)
* Motrin (Ibuprofen)
* MotrinIB (Ibuprofen)
* Naprosyn (Naproxen Sodium)
* Naproxen (Naproxen Sodium)
* Sansert (Methysergide)
* Tylenol (Acetaminophen)
* Zomig

Heart - With the exception of angina (chest-pain) meds (ISMO, IMDUR, ISORDIL), most cardiovascular medications are approved on a case by case basis. MORE (see: arrhythmia, blood pressure, blood thinners, cholesterol)

Hepatitis C - Pegasys (Peginterferon alfa-2a), Rebetron (Ribavirin and Interferon alfa-2b), Roferon-A (Interferon alpha -2a), Roferon-A (Interferon alfa-2a, Recombinat) are NOT acceptable to the FAA.
Hepsera (Adefovir Dipivoxil) and Rebetol (Ribavirin) MAY be approved by the FAA on a case by case basis only.

Herbal - Most herbal preparations are approved by the FAA provided there are no side effects and the condition being treated is not disqualifying. MORE

Herpes - The following medications are approved by the FAA on a case by case basis:

* Famvir (Famciclovir)
* Valtrex (Valacyclovir)
* Zovirax (Acyclovir)

HIV - Antiretroviral medications may be FAA approved on an individual basis if prescribed in compliance with the 1996 DHHS Panel recommendations regarding the Clinical Practices for the Treatment of HIV.

Case by case approval may be obtained for:

* Epivir (Lamivudine)
* Fludara (Fludarabine)
* Hepsera (Adefovir Dipivoxil)
* Rebetol, Virazole (Ribavirin)
* Sustiva (Efavirenz)
* Truvada (Emtricitabine / Tenofovir)
* Viread (Tenofovir Disoproxil Fumarate)
* Zerit (Stavudine) MORE

Hormone Replacement - Teatment (Premarin / Estrogen) is approved by the FAA.

Hypertension - See Blood Pressure

Hyperthyroidism - Provided applicant is euthyroid, the following medications may be approved on a case by case basis only:

* Tapazole (Methimazole)
* Propylthiouracil

Infection - The use of antibiotics is often permissible, providing the drug is has been FDA approved for at least one year and has been used long enough (usually 48 hours) to rule out the possibility of adverse effects. A partial list of acceptable antibiotics include:

* Azactam (Aztreonam)
* Augmentin, Amoxil (Amoxicillin)
* Biaxin (Clarithromycin)
* Cipro (Ciprofloxacin)
* Floxin (Ofloxicin)
* Keflex (Cephalexin)
* Monodox (Doxycycline)
* Zithromax (Azithromycin)

Influenza Virus Infection - The following meds are FAA approved on a case by case basis:

* Relenza (Zanamivir)
* Tamiflu (Oseltamivir)

Impotence - See Erectile Dysfunction

Immune System Suppressants / Anti-Rejection Agents - Cellcept may be acceptable to the FAA on a case by case basis.

Insomnia - See Sleep

Infertility - Proxeed (acetyl-L-carnitine HCl) is approved on a case by case basis for male infertility.

Irritable Bowel Syndrome (IBS) - See GI

Kidney Stones / Renal Calculi - Alkalinizing and Cholelitholytic Agents, such as those below, are approved by the FAA on a case by case basis.

* Actigall, Urso (Ursodial)
* Oracit, Urocit-K 10, Urocit-K 5 & Bicitra (Sodium Citrate)
* Cytra-K & Polycitra-K (Potassium Citrate)
* Cytra-3 and Polycitra (Citric Acid)

Lipid Management- See Cholesterol / Lipid Management

Meniere's Disease - Dyrenium (Triamterene) is acceptable on a case by case basis only.

Migraine - The following drugs are FAA approved on a case by case basis only and depend upon the manifestation and severity of the migraine:

* Axert (Almotriptan Malate)
* Beta-Blockers (when labeled & approved by the FDA for migraines)
* Caffergot
* Calcium-Channel Blockers
* Imitrex
* Innopran XL (Propranolol Hydrochloride)
* Maxalt (Rizatripatan)
* Sansert
* Zomig (Zolmitriptan)

Mood Enhancing - With the exception of herbal preparations, mood ameliorating medications are not approved by the FAA.

Motion Sickness - Ginger root is an acceptable treatment for the prevention of benign motion sickness. MORE

Mouth Infection Prevention - Most mouthwash type medications, including prescriptions drugs such as Chlorhexidine Gluconate, are FAA approved.

Multiple Sclerosis - The following are FAA approved on a case by case basis:

* Avonex (Interferon BETA-1a)
* Copaxone Subcutaneous (Glatiramer Acetate)

Myasthenia Gravis -
Mestinon (Pyridostigmine) may be approved on a case by case basis.

Narcolepsy (See Sleep)

Nerve Agent Poisoning (PREVENTION)
Mestinon (Pyridostigmine) is acceptable for prophylactic nerve agent poising.

Obesity - Xenical (Orlistat) may be FAA approved after 30 days without negative side-effects and on a case by case basis.

Osteoarthritis - See Anti-Inflammatory & Arthritis

Osteoprosis - The following may be FAA approved on a case by case basis:

* Evista (Raloxifen)
* Fosamax (Alendronate)

Pain Control - The following medications are usually FAA approved provided there are no side effects and the condition being treated does not preclude safe performance of flight duties:

* Advil
* Aleve
* Ansaid
* Celebrex
* Indocin
* Mediprin
* Motrin
* MotrinIB
* Naprosyn
* Tylenol
* Voltaren

Botox (derivative of the botulism bacteria) may be approved on a case by case basis.

Prolactinoma / pituitary disorders - Dostinex (Cabergoline) may be acceptable for treatment of pituitary disorders (prolactanoma) .

Parkinson's Disease - Many drugs such as Requip (Ropinirole) , Mirapex
(Pramipexole Dihydrochloride) , and Permax (Pergolide) are not acceptable to the FAA. The following are approved on a case by case basis only:

* Atamet, Sinemet (Carbidopa + Levodopa)
* Atapryl, Carbex, Eldepryl, Selpak (Selegiline Hydrochloride)
* Comtan (must demonstrate no adverse effects)
* Parlodel (Bromocriptine)
* Symmetrel (Amantadine Hydrochloride)

Periodontitis - Most mouthwash type medications, including prescriptions drugs such as Chlorhexidine Gluconate, are FAA approved.

Polycythemia - Hydrea (Hydroxyurea) is approved by the FAA on a case by case basis.

Psychiatric- With the exception of herbal preparations, psychotropic medications are rarely approved by the FAA. MORE

Prostate - The following may be FAA approved for Prostate Cancer on a case by case basis:

* Casodex / Zolodex (Bicalutamide)
* Leuprolide Acetate (Lupron Depot)
* Radioactive seed implantation

The following are approved by the FAA for the prevention or treatment of Benign Prostatic Hypertrophy (BPH) on a case by case basis:

* Cardura (Doxazosin Mesylate)
* Dibenzyline (Phenoxybenzamine HCL)
* Flomax (Tamsulosin HCL)
* Hytrin (Terazosin HCL)
* Minipress, Minizide (Prazosin HCL)
* Proscar (Finasteride)
* Saw palmetto
* Uroxatral (Alfuzosin hydrochloride)

Renal Calculi - See Kidney Stones

Restless Leg Syndrome - Some commonly prescribed drugs such as Neurontin (Gabapentin) are not approved by the FAA. The following may be approved by the FAA on a case by case basis only:

* Atamet
* Parlodel
* Sinemet

Seizure - Anti-seizure medications are NOT FAA approved for pilots. MORE

Sickle Cell Anemia - Droxia (Hydroxurea) may be FAA approved on a case by case basis.

Scleroderma, Peyronie's Disease - Potaba (Aminobenzoate) may be acceptable on a case by case basis.

Skin - Cosmetic wrinkle treatments with Botox (Botulinum Neurotoxin) may be FAA approved on a case by case basis with restrictions.

Skin ACNE - See ACNE

Sleep Disorders- Sleep prevention medications, such as Provigil (Modafinil), are not approved by the FAA. Most sleep aiding medications are NOT approved by the FAA. This includes:

* Halcion (Triazolam)
* Restoril (Temazepam)
* Sonata (Zaleplon)

Ambien (zolpidem) may be acceptable to the FAA on a case by case basis with 24-48 hour wait after use. Over-the-counter medications such as Tylenol PM or Excedrin PM (Acetaminophen, Diphenhydramine Hydrochloride) may be acceptable for temporary insomnia with a satisfactory grounding period. Melatonin is approved for pilots WITHOUT sleep disorders. MORE

Smoking Cessation - Nicotine patches or gum is approved on an individual basis. Zyban (Bupropion hydrochloride) or other mood ameliorating drugs may be utilized to quit smoking but must be discontinued prior to FAA approval. MORE CESSATION INFO

Steroids - Topical steroids may be approved for the treatment of minor dermatological conditions on a case by case basis:

* Cortef (Hydrocortisone)
* Florinef (Fludrocortisone acetate)
* Low doses (<20mg) of Prednisone

Thyroid - Medications such as Synthroid (Levothyroxin) , used to stabilize thyroid function are usually approved but only an an individual basis.

Topical - Accutane is approved treatment of acne during daytime flight only. Most topical medications for acne or similar conditions may be approved by the FAA.

Ulcer - The use of prophylactic medications for the peptic ulcer illnesses, such as antacids, H-2 blockers, and Sucralfate may be allowed, depending on the specific condition and severity. Favorable FAA consideration requires extensive evaluation. Medications approved on a case by case basis include:

* Aciphex (Rabeprazole)
* Asacol (Mesalamine)
* Axid (Nizatidine)
* Azulfidine ((Sulfasalazine) )
* Cytotec (Misoprostol)
* Dipentum (Olsalazine)
* Mylanta
* Pepcid (Famotidine)
* Prevacid (Lansoprazole)
* Prilosec (Omeprazole)
* Propulsid
* Protonix (Pantoprazole sodium)
* Reglan (Metoclopramide hydrochloride)
* Rolaids
* Tagamet (Cimetidine)
* Tums
* Zantac (Ranitidine)

Ulcerative Colitis - The following are approved on a case by case basis only:

* Asacol (Mesalamine)
* Azulfidine (Sulfasalazine)
* Dipentum (Olsalazine)
* Imuran (Azothioprine)
* Pentasa (Mesalamine)
* Remicade (Infliximab)

Uterine Bleeding / Fibroids - Luprin, Lupron (Leuprolide) may be FAA approved on a case by case basis.

Vaccinations - Prophylactic injections such as; immunizations or B-12 shots are usually approved provided there are no side effects.

Viral Infection - The following anti-viral medications are approved by the FAA on a case by case basis:

* Famvir (Famciclovir)
* Rebetron, Virazole (Ribavirin)
* Valtrex (Valacyclovir)
* Zovirax (Acyclovir)

Weight Loss / Management - Fenfluramine (Pondimin), Phentermine (Adipex), Dexfenfluramine (Redux) are NOT acceptable to the FAA.

Xenical (Orlistat) is approved after observation for adverse effects. While some over-the-counter or herbal preparations are not regulated by the FAA, they may have a high incidence of adverse side effects. MORE

Xerostomia (Dry Mouth) - Salagen (Pilocarpine Hydrochloride) may be FAA approved to promote saliva on a case by case basis.

 

 


 

 

Another Health Tip: Aspirin

My wife was in cardiac research in San Diego and said that if you are having an acute myocardial infarction (AMI or MI), commonly known as a heart attack, a disease state that occurs when the blood supply to a part of the heart is interrupted, coughing will not help, but if you are suffering from heart rhythm problems (arrhythmias) which occur when the electrical impulses in your heart become irregular, it might convert you and cause your heart to start beating normally again or more normal. Web Med talks about a possible help but warns not to just let it go and seek medical attention. Hey, if you are waiting for the ambulance and have nothing better to do, why not give it try...might not die. If you are having the big one "MI", you are hoping they can get you to a hospital for blood thinners,clot busters, angioplasty, stents or a by pass. Carrying a box of aspirin around with you possibly help if you are lucid enough to take a couple and thin your blood enough to get you to the hospital. If you have a major blockage you will probably not be awake to do any thing for yourself. Just saying coughing is false because of Snoops is no answer. You have to have the whole educated picture. If you are in a state of health that is likely to cause a heart attack, do your home work on what you can or cannot do for your self while waiting for professional medical attention.

    *     *    *     *

If aspirin smells like vinegar it is no good. If you think you might  be having a cardiovascular incident chew 2 aspirin.

Recognizing a Stroke

There are 2 types of stroke...ischemic and hemorragic. 75% of strokes  are ischemic, resulting from complete occulsion of an artery that  deprives the brain of essential nutrients. These occulsions are caused
by blood clots that develop within the brain artery itself (cerebral  thrombosis) or clots that arise elsewhere in the body then migrate to the brain (cerebral embolism). Aspirin would help here, but...if you have a hemorragic stroke (either rupture of an artery with bleeding onto the surface of the brain [subarachnoid hemorrhage] or bleeding into the tissue of the brain [intracerebral hemorrhage] aspirin would worsen the intraccerebral bleeding.

Garry Clark

   *     *    *    *

Just to add an agreement on the brain bleed and warning not to take aspirin. If you have a speech problem, Aphasia (or aphemia) is a loss or impairment of the ability to produce and/or comprehend language, due to brain damage. This as stated could be a clot which aspirin might help or a bleed which will worsen the condition.

Do not confuse a heart attack with a stroke. If you are having aphasia, you have a short time to get to the hospital for them to decide whether it is a bleed or clot. You have about a 3 hour window if they are going to administer the clot busting drugs. My sister in law had this a couple of years ago. Some one wrote some time back to use the word STR. Ask them to Smile, Talk coherently, and Raise both arms. If they fail one or more of the three they may be having a stroke. Or it could just be late into happy hour....enjoy life, it is the only one you have



RECOGNIZING A STROKE


Sometimes symptoms of a stroke are difficult to identify. Unfortunately, the lack of awareness spells disaster.
The stroke victim may suffer brain damage when people nearby fail to recognize the symptoms of a stroke.
Now doctors say a bystander can recognize a stroke by asking three simple questions:
1. *Ask the individual to SMILE.
2. *Ask him or her to RAISE BOTH ARMS.
3. *Ask the person to SPEAK A SIMPLE SENTENCE (Coherently) (i.e. . . It is sunny out today)
If he or she has trouble with any of these tasks, call 9-1-1 immediately and describe the symptoms to the dispatcher.
After discovering that a group of non-medical volunteers could identify facial weakness, arm weakness and
speech problems, researchers urged the general public to learn the three questions. They presented their
conclusions at the American Stroke Association's annual meeting last February.
Widespread use of this test could result in prompt diagnosis and treatment of the stroke and prevent brain damage.
A cardiologist says if everyone who gets this e-mail sends it to 10 people; you can bet that at least one life will be saved.


BE A FRIEND AND SHARE THIS ARTICLE WITH AS MANY FRIENDS AS POSSIBLE, you could save their lives.


From: Larry Walters

We want to point out the trouble a pilot can get into if a doctor or
technician writes something incorrectly regarding a physical exam.
More importantly, he didn't mention the horrors involved in getting on the "special issuance" list with the FAA Medical Department.

    *     *     *
Note from Moderator Pete Sofman:

For those of you who, like me, do not know anything about this "special issuance", here's a short blurb about it and other FAA sites.

For more information, go to: http://tinyurl.com/3bfsa5

Authorization for Special Issuance of a Medical Certificate and AME
Assisted Special Issuance (AASI)

1. Special Issuance.

At his discretion, the Federal Air Surgeon may grant an
Authorization for Special Issuance of a Medical Certificate (Authorization), with a specified validity period, to an applicant who does not meet the
established medical standards. The applicant must demonstrate to the
satisfaction of the Federal Air Surgeon that the duties authorized by the
class of medical certificate applied for can be performed without
endangering public safety for the validity period of the Authorization. The Federal Air Surgeon may authorize a special medical flight test,
practical test, or medical evaluation for this purpose.

An airman medical certificate issued under the provisions of an
Authorization expires no later than the Authorization expiration date or
upon its withdrawal. An airman must again show to the satisfaction of
the Federal Air Surgeon that the duties authorized by the class of
medical certificate applied for can be performed without endangering public
safety in order to obtain a new airman medical
certificate/Authorization under Title 14 of the Code of Federal Regulations (14 CFR) §67.401.


URPBPA) WEBSITE UPDATE 12-30-06

The United Retired Pilots Benefit Protection Association (URPBPA) has had discussions with the United Benefits Service Center about
United’s failure to mail 2007 medical insurance plan payment coupons to the retired pilots. The representative at the Benefits Service Center
stated that the January 2007 payment coupons would be mailed approximately January 5, 2007. They also said that there would be a forty-five day grace period for the January payment. The reason given for the delay was that the payments amounts for many retirees will change with the January payment and it was taking longer than normal to process the revised coupons.

URPBPA’s attorneys are seeking to verify this information with
United.

While URPBPA cannot vouch for the accuracy of this information at this
time, we felt it would be helpful for retirees to know what the Benefits Service Center is telling those who call and ask about the January
payment. URPBPA strongly suggests that retirees make the January 2007 payment as soon as they receive the coupon from United in order to avoid United canceling their medical insurance coverage.

Retirees who have their payments automatically made from an account should also check with their financial institution and the Benefits
Service Center to insure that the proper amount is paid for January
2007.


Nov 15, 2006,   received from JFKFO retiree Ray Cicola:
============ ========= ======
... (regarding) the new post medicare medical/drug option
called United Medicare Select ...here is what I was told by UAL
retiree service center:

1. Medical coverage is the same- changes are in drug plan

2. Max out of pocket old plan = $1500 New = 3,850

3. Non AFA People who retired before 2003 have freeze on drug copay
($19 Generic & $48 Brand name). I spoke to 3 different agents - 2
said if you take new option it is undetermined whether you get the
freeze back if you return to the old plan during next open enrollment.

The Third person said freeze will be lost forever if you go with new plan.

4.The new and old drug program qualify with medicare as creditable
coverage, which neans that if, for some reason, you change to
medicare drug program in the future you will not be penalized for late
enrollment.

5. My savings per month at age 65.5 for New medicare select plan is
$28.68 per month for each family member post medicare.

Soooooo...my conclusions. ...as with all insurance it is a gamble...If
you don't use name drugs, you could save $28.68/month. If your drug
needs increase substantially, you have to ride out the present year
with increased out of pocket which may be more than your monthly
savings. Then return to old plan with probable loss of freeze during
next open enrollment.

Regards, Ray


Oct. 23

From R.Brooks

I guess I am a slow learner. BCBS has informed me that the UAL plan for retired pilots and family over 65 is called a "carve out" plan
and is not a "medicare supplement" plan. In UAL's mailings they euphemistically call this a maintenance of benefits plan.

Does anyone have a grip on the significance of this change? Besides the $1500 annual out of pocket, the plan seems to seriously limit any
payments beyond the medicare approved fees. I think there is a potential for a major financial surprise for anyone who receives
hospital or surgical care without confirming that the provider accepts medicare assignment.

If anybody has this figured out, please jump in. If this has been hashed out before, my apologies in advance.

- Oct 25

To Dick and all interested:

Dear Dick Brooks.

You are correct that the UAL medical plan is a "carve out" plan. This plan was agreed to by the 1114 retired pilots committee (of which I was a member) as well as all other bargaining teams representing other union employees and retirees at United. Our specialist in this field alerted us to the disadvantages of this form of insurance coverage and we bargained to achieve the best possible plan for all employees and retirees given the company's posture that the form of coverage we had enjoyed pre-bankruptcy was no longer an option. The initial proposal offered to us by the company was far worse and would have transferred most of the cost of medical insurance to the employee, the retiree, or the retiree's surviving spouse with increases in premiums over time. The new agreement recognizes the increase in medical premiums over time but limits them to a fixed percentage which does not approach the current increases in premiums endured by the population at large. I regret that we could not do more for the pilot retirees and others in the company but please understand that we have not been singled out for anything less than the other bargaining groups achieved.

Alan L. Black


Nov 2,2006

From:  Dick Brooks

Alan, your work on the 1114 committee is much appreciated by me and I'm sure, most retired pilots. The $1500 out of pocket drives one to
consider alternatives. I can purchase AARP's "J" plan for $176/month plus $176 for my wife. This plan picks up all of medicare's
deductibles and imposes none of it's own. It also covers provider charges beyond medicare assignment amounts.

There are two problems with this course of action. Existing conditions are considered by the underwriter unless our current plan
is terminated. Without termination, you will have to submit a medical statement which could be used to deny coverage for pre-
existing conditions. This restriction disappears after a fixed time period, typically one year. If our plan were to be teminated we
would have 60 days to enroll in a new plan of our chosing with no underwriter review of our medical history and no restrictions for pre-
existing illness. Considering the instability in our industry everyone should remember this 60 day window.

Secondly, our Medco expenses cannot be improved on and probably cannot be matched by an individual. The best Medicare "D"
plan available in my area would cost me $1800 per year for my current RXs. More than double what I pay Medco currently. The
politicians are promising improvements in part D but until then keep breathing.

Combining the drug and health care issues above it would seem that Fromchanging insurance at this point probably doesn't make sense, yet.

(Caution, writer has no expertise in this area)

Thanks to all for the discussion.

Dick Brooks


Aug. 26th 2006

-- bob enander <pattibob2@tampabay.rr.com wrote:

 I really didn't know who to send this to, but I would like to see a survey on how many of us have had bouts with skin cancer. Many of us sat under those bubble canopies in the military and then 25-40 years  with UAL with 25,000 -40,000 ft. less atmosphere to filter out the UV's. Granted in the military we were covered up pretty well with hard hat and mask but I'm sure we still got hit.

 As I sit here writing this, with 25 stiches in my face from surgery yesterday to get a Basal lump out of my right cheek, I couldn't help but wonder if the airline Industry leaders or the aircraft manufacters

 have done anything (UV protection on the canopies and windscreens) to remedy the situation or are they just ignoring the problem.

 Also ALPA should look into this.  My Dermatologist told me that his contemporaries have know of this problem for some time and are astounded that something wasn't done in the 60s when Jetliners came out, but even more amazed that the problem appears to still be uncorrected. For several years now I have been getting treatment (freezing) every 3-4 months and this is the 3rd Basal cell I've had removed.

 Thanks, Bob Enander 1955-1990 MDW ORD SFO ORD LAX

 ORD


August 14, 2006

On April 7,2006 I wrote about being unable to enroll my wife in a Medicare,Part D, prescription drug plan. United had failed to update BC/BS of the "Termination" of my wifes coverage(My election) on 01/01/2006.


This is an update of the problems concerned. Each month we would enroll my wife if Part D and each month a sort of "Sweep" by Medicare would say she was NOT eligible because of prior coverage under a previous employer", and she would be dropped.


Finally, as a last resort, I took all pertinent documents to the office of my congressman. I am happy to report that this is what it took to get the office of the VP, United Airlines Benefits, to recognize that they had NOT notified medicare of the termination of my wifes plan. Seems that when there was a rush job about Part "D" prescription plans early this year, they simply sent a list to medicare with everyone over 65(Done in Mid January) "ASSUMED" to be still enrolled in United BC/BS medical plan which does have prescription drug coverage.


As I write this, the medicare web site still has my wife covered by United BUT someone at Medicare has overridden the error and thus she has been able to get her own drug coverage!


It took a contact by my congressman to a local Medicare office, with proof that my wife had terminated her United coverage, to get a Part D plan.


Please post this to the Medical Insurance part of the site. Louis C. Paulin, retired, 064259


New Blood Test For Prostate Cancer

April 26, 2007

(WebMD) An experimental blood test for prostate cancer seems to work better
than the current PSA test - and can tell whether the cancer is spreading.

The new test looks for a protein called EPCA-2, early prostate cancer
antigen 2. Unlike the PSA (prostate-specific antigen) protein on which the
current PSA test is based, this protein isn't found in normal prostate
cells. Instead, EPCA-2 occurs in relatively large amounts only in prostate
cancer cells.

The test is being developed by Robert H. Getzenberg, Ph.D., director of
urology research at Johns Hopkins University's Brady Urological Institute.
Getzenberg began the work while still at the University of Pittsburgh; the
test has been licensed to the Seattle biotech firm Onconome Inc.

"We wanted to find something that really identified people with prostate
cancer and not people with enlarged or infected prostates," Getzenberg tells
WebMD. "This is as close to cancer specific as we could find. We found it is
very unique. It is 97 percent specific, meaning that if you test positive
there's only a 3 percent chance you don't have prostate cancer."

Getzenberg has a financial interest in the test. But experts who do not
stand to gain from the test agree that it has enormous potential.

Otis Brawley, M.D., chief of the solid tumor service at Emory University's
Winship Cancer Institute, calls the test "important" and predicts it will be
widely used.

Charles A. Coltman Jr., M.D., associate chairman for cancer control and
prevention at San Antonio's Southwest Oncology Group, calls the findings
"striking" and "remarkable, " although he warns that the test has been tried
out on only a small number of patients.

Ganesh Palapattu, M.D., assistant professor of urology at the University of
Rochester, agrees that more studies must be done. But he tells WebMD that
the test is a big step toward the "Holy Grail of prostate cancer detection:
not so much identifying men with prostate cancer, but identifying men with
prostate cancer who have aggressive disease."

"This not only helps tell whether you have prostate cancer, but what kind of
prostate cancer you have," Getzenberg says.

Getzenberg and colleagues report early studies of the EPCA-2 test in the
April issue of the journal Urology.

EPCA-2 Test Beats PSA

Nobody is entirely happy with the current PSA test for prostate cancer. A
man without prostate cancer can have high PSA levels. A man with advanced
prostate cancer may have very low PSA levels.

Getzenberg's team tried out the EPCA-2 test on blood samples from several
different groups of people. Some were known to have early prostate cancer or
late prostate cancer, and some had other kinds of cancer. Some had enlarged
prostates, but not cancer. Some were women, who have no prostate gland. And
some were healthy men with normal PSA levels.

Both in terms of detecting cancer when it was actually there (sensitivity) ,
and in terms of not detecting cancer when it wasn't actually there
(specificity) , the EPCA-2 test beat the PSA test.

More importantly, it beat the PSA test in predicting whether prostate cancer
already had spread outside the prostate gland. When that has happened,
standard treatments for prostate cancer - radical prostatectomy (surgery to
remove the prostate) and brachytherapy (tiny radioactive seeds implanted in
the prostate) - fail to cure.

"I predict that within the next year, this test is going to be widely used
to find the guy who has prostate cancer and who, if he got radical
prostatectomy, would relapse very quickly," Brawley tells WebMD. "It is
going to say to this guy, 'Skip the unnecessary surgery and get pelvic
radiation and hormone treatment now.'"

Getzenberg says it will be at least two years before the test is "out on the
street" with FDA approval. All of the experts who spoke to WebMD agree that
large-scale screening tests will be needed before it's known exactly how
well the test works.

"What we really need to know is how this test behaves in all comers, when we
don't already know whether the men being tested have prostate cancer,"
Palapattu says. "It would also be important to identify men with high risk
of prostate cancer vs. low risk of prostate cancer, and to test men after
prostate surgery to see whether it can predict cancer recurrence."

When, and if, the EPCA-2 test is approved, men will still need better
prostate cancer tests.

"At least a third, maybe two-thirds of guys with localized disease have
cancer that will never leave the prostate and never bother them," Brawley
says. "This new test is not going to help those guys who get treated for
prostate cancer but shouldn't. I hope there will be help for these men
soon."

By Daniel DeNoon
Reviewed by Louise Chang, M.D.

More useful information:


Following is an old item on prostate testing, followed by a response from my doctor to the article.

To: Chuck Mathis


HI CHUCK


Thanks for the information. It appears the test is not currently available unless you contact Dr. Getzenberg directly.
You have to realize that a test that decreases the large numbers of prostate biopsies can significantly reduce the income of many urologists and facilities. Don't be surprised to see main stream medicine attempt to quash this information and testing. The same thing happened with digital infra-red thermographic testing of the breast, approved by the FDA in 1982 -- it does not cause cancer (as standard mammograms do) and all but eliminates unnecessary breast biopsies, again, a major cash cow for many specialists in the country.


Thanks and keep me posted,


Here is an article from last August with additional information about
the EPCA-2 research.

The test appears much more accurate than the
standard PSA test in detecting prostate cancer. If the timeline at
the bottom of the article is correct it would appear that the test
will be available in about a year. Would like to hear if anyone has
any more updated information on when test will be available to public.

Hopkins Researchers Find Better Blood Test for Prostate Cancer
August 23, 2006

New studies of a blood protein recently identified at Johns Hopkins,
early prostate cancer antigen-2 (EPCA-2), may change the way men are
screened for prostate cancer -- a disease that kills tens of
thousands of men every year.

Current standards of screening and testing for prostate cancer focus
on the blood protein prostate-specific antigen (PSA) along with a
digital rectal examination. Men who have more than 2.5 nanograms per
milliliter of PSA are considered at risk for prostate cancer.

However, PSA testing often erroneously highlights non cancerous
conditions (false positives) and can miss some cases of cancer (false
negatives), according to Robert H. Getzenberg, Ph.D., a professor of
urology and director of research at the James Buchanan Brady
Urological Institute at The Johns Hopkins University School of
Medicine.

Due to elevated PSA levels, approximately 1.6 million men undergo
prostatic biopsies in the United States annually, and roughly 80
percent of these men have negative results, according to Getzenberg,
lead author of the study.

He says that of the entire population of men in the United States who
have been tested for PSA, an estimated 25 million have elevated PSA
levels and a biopsy of the prostate that did not reveal any prostate
cancer. Conversely, roughly 15 percent of men with prostate cancer go
undetected because their PSA levels are below the cutoff level,
according to Getzenberg.

In a study published online in Lancet, Getzenberg and a team of
Hopkins researchers introduce evidence in support of EPCA-2 testing
as a more accurate way to identify cancer in the prostate.

"A blood test based on EPCA-2 may greatly improve our ability to
accurately detect prostate cancer early and minimize the number of
false positives, therefore lowering the number of unnecessary
biopsies," says Getzenberg. "In addition, this is the first time we
have a test that effectively distinguishes between men with cancer
confined to the prostate and those whose disease has spread outside
of the gland."

Getzenberg and his team measured EPCA-2 levels in the blood of 330
Hopkins patients separated into several groups: men with normal PSA
levels and no evidence of disease, men with elevated PSA levels but
who had negative biopsies, men with a common non cancerous prostate
condition known as benign prostatic hypertrophy (BPH) who did not
receive biopsies for prostate cancer, men with prostate cancer but
with normal PSA levels, men with prostate cancer confined to the
prostate, men with prostate cancer that had invaded outside of the
gland at the time of surgery, and a diverse group of patients with
benign conditions of other organs as well as individuals with other
cancer types.

Patients with an EPCA-2 cutoff level of 30 nanograms per milliliter
or higher were considered to be at risk for prostate cancer. This
cutoff value was established in a pilot study of 30 blood samples and
was then applied throughout the larger study.

Results showed that the EPCA-2 test was negative in 97 percent of the
patients who did not have prostate cancer. Men with no evidence of
disease (regardless of their PSA levels), as well as the control
group of patients with other cancer types and benign conditions, all
had EPCA-2 levels below the cutoff.

In contrast, in a multi-institutional study published in 2003 in the
Journal of Urology, PSA levels between 4 and 10 nanograms per
milliliter were shown to be accurate in identifying patients without
prostate cancer only 19 percent of the time.

In addition, 77 percent of the BPH patients had a level of EPCA-2
lower than the cutoff point. Getzenberg says this is well within the
likely percentage range of BPH patients who are prostate-cancer free.
He says this result was encouraging since BPH is often associated
with elevated PSA levels, leading to misdiagnosis and unnecessary
biopsies.

When it came to correctly identifying patients with prostate cancer,
EPCA-2 levels at or above the cutoff were detected in 90 percent of
the men with organ-confined prostate cancer and 98 percent of the men
with disease outside of the prostate. Overall, in this study, the
EPCA-2 test detected 94 percent of the men with prostate cancer.

The 2003 study showed that PSA levels between 4 and 10 nanograms per
milliliter detected 85 percent of the patients with prostate cancer.

Results of the study also revealed that EPCA-2 levels were
significantly higher in patients whose cancers had spread outside of
the prostate compared to those with disease confined to the gland.
EPCA-2 was dramatically better at separating these groups than were
PSA levels, according to Getzenberg.

"This is important since cancer that has spread outside of the
prostate is more deadly, which makes it even more crucial to have a
tool that detects it early," says Getzenberg.

Finally, the EPCA-2 test identified 78 percent of the men with
prostate cancer in the group with PSA levels below the accepted
cutoff level of 2.5 nanograms per milliliter.

EPCA-2 is the second prostate-cancer marker identified by Getzenberg
and his team that has outperformed PSA. Last year, they discovered an
unrelated tissue-based test, EPCA-1, that also proved effective at
identifying prostate cancer. The only commonality between these
markers is that they were discovered using the same approach.
Getzenberg says the efficacy of EPCA-1 as a test of biopsy samples is
currently being evaluated.

Prostate cancer is the most common type of cancer found in American
men. The American Cancer Society estimates that there will be
approximately 234,460 new cases of prostate cancer in the United
States in 2006, and 27,350 men will die of this disease.

Getzenberg says larger clinical trials for EPCA-2 are planned that
could make this test available to the public in approximately 18
months.

More on the same subject:

http://tinyurl. com/2d6r5n

Some contact info:

1. Computershare's phone number is 312-588-4267 and toll-free 800
919 7931 .
Some guys are having better luck with the 312 number.

2. re Life Insurance Questions:

a. Mary Lou Gleason, Benefits Analyst - Strategy & Design
United Airlines WHQHR, P. O. Box 66100, Chicago, IL 60666

b. Cigna Group Insurance: Pauline Jimenez, customer service (1-800-
423-1282). ...regarding the Flexible Term Life Coverage Termination
from Connecticut General.

3. For questions regarding why you have received the distribution,
the
amount that you were entitled to as part of the distribution, and/or
the
taxes withheld on the distribution, please call the United Share
Distribution Hotline at 877.752.5527 or (503) 277-7999
(Poorman-Douglas).

This is the e-mail I received from ADP regarding the coupons. (ADP = Automatic Data Processing, the company handling this stuff.)avn

Good Afternoon,

A quick update for you on January Coupons for Retiree's:

* The retiree direct bill file(s) have been loaded and all error reports completed.
* An audit was performed on the file(s) to validate that all retiree DB participant records loaded
* January DB coupons for retirees will begin to generate tonight.
* A message has been placed on the IVR to notify retirees of the delay in mailing January coupons and January 9th ACH date.

If you have any questions let me know.

Thank you and Have a Great Day!

Perricone, Catherine [WHQIN]

 

 

 

From: Graham Norris,

Here's what I've gleaned after looking into insurance with Medicare: Essentially there are two forms of addon coverage to medicare; Medicare Advantage and Medicare Supplement, plus Part D.

First of all, it makes no sense to opt out of Medicare - unless you have coverage through the VA.

Medicare Advantage has broader coverage - like dental and optical, but requires a copay each time. It is the most popular because it is the cheapest (some insurance companies "refund" the premium or provide coverage for "free"). BCBS provides a direct Advantage plan for about $35.00 per month. Advantage does not include medicine. The premium is the same for all ages.

Supplimental is more expensive and comes in several flavors - A through G, with G being the most comprehensive and costly (around $110 - $130 per month for type "G" at age 65) The premium goes up with age (max around $180/month). There are no copays and coverage is 100% (after medicare, of course), however it does not cover some services, like dental, vision, etc. In effect the coverage is deeper but not as broad as an Advantage plan.

The coverage in either Advantage or Supplimental is the same from all insurance companies. In other words the name defines the coverage. The premium varies slightly from company to company, based upon the actuarial experience of the company.

Part D provides medicine. There seems to be a lot of wriggle room in D, and coverages and premiums vary widely. Not all companies provide all medicines. They charge varying copays. Some charge less for generics and a lot more for exotic drugs. Many Part D's have a lapse in coverage after paying out so much in a year until your out-of-pocket costs reach some certain amount (like $1200). This is sometimes refered to as "the hole" or "the doughnut." The premium is around $35.00/month.

In simple terms, Medicare provides for hospitalization, Advantage and Supplimental provide for the non-hospital costs (Doctor, therapy, etc), and Part D provides the medicine.

So, what to do? In my case, where my wife is 7 years younger than I, I am planning on keeping her in United's BCBS pre-medicare coverage, keeping United's "Part D" and buying Supplimental coverage G from Connecticut General for me. The net cost is slightly less than the group coverage alone, but the coverage is significantly better.


Graham Norris

(

 

 

And earlier this summer I received this info.  ed

Substantial Medicare Part B fee increases were contained within the law that established the Medicare drug program. This is the first time I have seen these figures. I thought it would be good for retirees to have a heads up warning of what is to come. This info is from MOAA. a military retirement organization I belong to. Dave Malone


Substantial Increase in Medicare Part B Premiums Coming for Some in 2007

Passed as part of the 2003 Medicare modernization law that established the Medicare Part D drug program, Congress implemented a plan to increase Part B charges for millions of senior-aged Americans. Beginning on January 1, 2007 the government will begin means -testing for Medicare Part B premiums. This could result in substantially higher Part B premiums for many members.

Currently, Part B premiums are set to cover 25 percent of the government's total cost per individual to provide Medicare benefits. Beneficiaries pay ($88.50 per month, per person) and the government pays the remaining 75 percent ($265.50). Under the law, some higher-income beneficiaries will see their Part B premiums doubled or tripled by 2009, as their premiums will be raised to cover a higher share of the government's total cost.

Those premium increases will be phased in over three years with 30 percent of the increase coming in 2007, 67 percent coming in 2008, and the full increase in 2009. MOAA remains as concerned today as we were three years ago about this plan to means-test what was enacted to be a universal health insurance plan for all older Americans.

Taking into account annual increases in Medicare Part B due to inflation, the chart details what premiums may look like over the required 3-year phase-in of the means-testing system. Those persons filing jointly should double the "Individuals" income levels.

 


 

NEW:  4/7/2006

This is my first shot at a communication so I am probably doing it incorrectly. I wanted to pass on some info that it took me about eight hours of phone call frustration to glean.
First of this year I "voluntarily withdrew" my wife from the Blue Cross/Blue Shield Traditional Medical plan thru United and got her her own "Medigap" Policy with USAA where they pay everything that Medicare does not, including the deductibles.
I tried to sign my wife up for Medicare Part-D, prescription drug coverage. I signed her up on the Medicare web site, got a confirmation number that said she was "Enrolled".
A few days later I got notification that she could NOT be enrolled because of "Prior coverage" thru her employer plan that was "equal to or better" than Part-D. Remember, she was removed from said coverage 01/01/2006.
Hours of frustration later I finally tracked the problem to BC/BS failing to electronically notify Medicare that my wife was no longer covered. They do this by magnetic tape which may take 60-90 days to be sent and received by Medicare.
Until the incorrect data about double coverage is removed from her Medicare records(You cannot do it yourself or send them proof, like the letter I got from BC/BS saying she is NOT covered), you cannot sign up for prescription Drug coverage under the "NEW" Medicare Part-D.


I would like this to be entered in the "Medical Benefits" part of the website. If I need to submit it another way, or another form, please let me know. Louis C. Paulin, 064259, ORD D10 S/O, Retired 11/01/2001.

Thanks, LOU


FYI - More from WHQHR - Dale T

This is a the predominate answer to the question - do we have Life insurance or not?

Dear Mr. Harper,

You recently wrote to Bud Cochran regarding information received from the United Benefit Service Center (UBSC) and the CIGNA call center (CBCA) regarding the termination of the retiree life insurance and the conversion rights. As you know, United reached an agreement with the Retiree Coalition during bankruptcy which included the termination of the retiree life insurance benefit in exchange for lowering retiree medical contributions. Below is the chronology and detail of the retiree life insurance termination for the Retiree Coalition group of retirees:

• Affected retirees received a packet from United Airlines dated July 16, 2004 that included information regarding the termination of retiree life. Affected retirees included those who retired before July 1, 2003 and were enrolled in retiree medical, including those retirees on voluntary suspension of medical (VSOP), as of July 1, 2004.

• The original proposed termination of retiree life date was 1/1/05. United Airlines and the Retiree Coalition worked on the life insurance valuation and retiree medical contribution issues through Fall of 2005. Therefore, termination of retiree life insurance was delayed and retirees retained coverage through 12/31/05.

• United approved the conversion letter that Cigna sent March 1, 2006 containing information on the optional conversion to an individual policy was sent to all affected retirees.

• CIGNA subsequently advised us that the life insurance coverage must remain in place through the conversion offering. Therefore, United kept the coverage in place through March 31, 2006.

Since CIGNA advised us that some retirees were still receiving letters last week, they have agreed to extend the conversion deadline to March 31,2006. Also, we have been assured that the UBSC and CIGNA are now communicating the accurate information regarding termination of coverage and the possibility of conversion.

Best regards,

Mary Lou Gleason

Benefits Analyst - Strategy & Design

United Airlines WHQHR

P. O. Box 66100

Chicago, IL 60666

1-847-700-9909

position of losing it forever because of a late premium, however uninte

***EN

                                                        ***************************************************

Important Notice from United Airlines

About Your Prescription Drug Coverage

World Headquarters 1200 East Algonquin Road Elk Grove Township, Illinois 60007 Mailing Address: Box 66100, Chicago, Illinois 60666

 

Dear Mr. Xxxxx:

United is required to send this Notice of Creditable Coverage to anyone who is eligible for Medicare. If you or one of your eligible dependents qualify for Medicare, please read and keep this important notice. You will also ,want to review the options described to determine if there is any advantage to enrolling in a Medicare-approved prescription drug plan. If you or one of your eligible dependents is not eligible for Medicare, you may disregard this notice. When the new Medicare prescription drug benefit goes into effect on January 1, 2006, United will continue to offer prescription drug coverage to eligible employees, retirees and their dependents. If you join a Medicare prescription drug plan, the Medicare benefit will automatically replace your current primary prescription drug coverage with United (if you currently are enrolled for such coverage).

Be sure to read this notice carefully and retain it as proof of your United Airlines prescription drug coverage.

1. Starting January 1, 2006, new Medicare prescription drug coverage will be available to everyone who is eligible for Medicare.

2. United Airlines has determined that the prescription drug coverage offered by the United Airlines Medical Plan for active and retired employees is, on average, for all plan participants, expected to pay out as much as the standard Medicare prescription drug coverage will pay. *

3. Read this notice carefully, it explains the options you have under Medicare prescription drug coverage and can help you decide whether or not you want to enroll.

* Although the current program will continue through 2006, United reserves the right to provide post-Medicare prescription drug benefits that are supplemental and secondary to Medicare Part D benefits in 2007.

If you currently have United'sprescription-drug-coverage, the fact-that this coverage is, on average, as good as the standard Medicare prescription drug coverage, allows you to keep this coverage and not pay extra if you later decide to enroll in Medicare coverage.

People who are eligible for Medicare can enroll in a Medicare prescription drug plan from November 15, 2005, through May 15, 2006. However, because you have existing prescription drug coverage that, on average, is as good as Medicare coverage, you can choose to join a Medicare prescription drug plan in the future. Each year, you will have the opportunity to enroll in a Medicare prescription drug plan between November 15 and December 31.

If you do decide to enroll in a Medicare prescription drug plan and drop your United Airlines prescription drug coverage, be aware that you may not be able to get this coverage back.

You should compare your current coverage, including which drugs are covered, with the coverage and cost of the plans offering Medicare prescription drug coverage in your area. Special rules apply when/if you can get the medical/prescription drug coverage reinstated. Retirees refer to the Voluntary Suspension rules in the medical section of your Summary Plan Description. Active employees refer to the Special and Open Enrollment rules in the medical section of your Summary Plan Description.

You should also know that if you drop or lose your coverage with United Airlines and don't enroll in Medicare prescription drug coverage after your current coverage ends, you may pay more to enroll in Medicare prescription drug coverage later. If after May 15, 2006, you go 63 days or longer without prescription drug coverage that's as good .as Medicare's prescription drug coverage, your monthly premium will go up at least one percent per month for every month after May 15, 2006, that you did not have that coverage. For example, if you go 19 months without coverage, your premium will always be at least 19 percent higher than what most other people pay. You'll have to pay this higher premium as long as you have Medicare coverage. In addition, you may have to wait until next November to enroll.

More information about your options under Medicare prescription drug coverage is available.

More detailed information about Medicare plans that offer prescription drug coverage will be available in October 2005 in the Medicare & You 2006 handbook. You should receive a copy of the handbook in the mail from Medicare. You may also be contacted directly by Medicare-approved prescription drug plans. More information about Medicare prescription drug plans is available:

. Visit www.medicare.gov for personalized help.

. Call your State Health Insurance Assistance Program (see your copy of

the Medicare & You handbook for their telephone number).

. Call1-800-MEDICARE (1-800-633-4227). TTY users should call

-1-877-486-2048.

The Medicare-approved prescription drug plan may be better for you if you have limited income and resources.

For people with limited income and resources, extra help paying for a Medicare prescription drug plan is available. Information about this extra help is available from the Social Security Administration (SSA). For more information about this extra help, visit SSA online at www.socialsecurity.gov, or call them at 1-800-772-1213 (TTY 1-800­325-0778).

For more information about this notice, please contact the United Benefits Service Center at 1-888-825-0188.

You may receive this notice at other times in the future, such as before the next period you can enroll in Medicare prescription drug coverage or if this coverage changes. You also may request a copy of this notice from the United Benefits Service Center.

Keep this notice. If you enroll in one of the new plans approved by Medicare, which offers prescription drug coverage after May 15, 2006, you may need to provide a copy of this notice to prove that you are not required to pay a higher premium amount. And remember: If you join a Medicare prescription drug plan, you will no longer have primary coverage under United Airlines' plan.

 

Sincerely,
David Fishman

Manager, Benefit Services